Alimera Sciences, Inc. (NasdaqGM:ALIM) announced that it has entered into a share purchase agreement for a private placement of 1,144,945 common shares, par value $0.01 per share, at a purchase price of $8.734044 per share for gross proceeds of $10,000,000 on April 14, 2021. The transaction included participation from Ocumension Therapeutics (SEHK:1477). The securities being issued are subject to a lock-up period of one year.

The company raised funding pursuant to Regulation D.